Skip to content

To Evaluate the Effects of Heating Device (Electronic Moxibustion) in Patients With Intradialytic Hypotension

To Evaluate the Effects of Heating Device (Electronic Moxibustion) in Patients With Intradialytic Hypotension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03856151
Enrollment
32
Registered
2019-02-27
Start date
2019-04-17
Completion date
2021-04-28
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis-Induced Symptom, Intra-dialytic Hypotension

Keywords

hemodialysis, Intra-dialytic Hypotension, heating device, electronic moxibustion

Brief summary

The aim of this study is to investigate the effects of heating device among otherwise stable patients with intradialytic hypotension

Detailed description

Intradialytic hypotension (IDH) is a common complication during hemodialysis (HD) which accounts up to 5 to 30 percent of all dialysis treatment and is associated with increased morbidity and mortality. The etiology of IDH is multifactorial, but intravascular volume depletion, autonomic neuropathy, and decreased cardiac reserve were the main factors. Several approaches were utilized to prevent IDH including adaptation of dialysis prescriptions, lengthening in dialysis time, avoiding food intake during dialysis, as well as limiting interdialytic sodium intake and administration of vasoconstrictor agents. However, it remains necessary to seek novel effective and safe inventions for IDH. To date, no studies have been done to evaluate the effectiveness of acupuncture and traditional moxibustion during HD for safety reasons (eg: risk of bleeding, burns and unpleasant smell). Therefore, the heating device appears to be a non-invasive and safe method for treating IDH. The investigators conduct a clinical trial using infrared heating devices without direct contact to the skin on low temperatures (56±8℃) in treating patients with IDH. 30 eligible participants diagnosed with IDH will be enrolled and divided into Group 1 and Group 2. Treatment 1# will be regular dialysis 3 times per week for 4 weeks. Treatment 2# will be regular dialysis 3 times per week plus HEALTHY BOX Powered heating pad on acupoint CV4 at the abdomen for 1 hour during dialysis, also for 4 weeks. For Group 1, each subject will receive Treatment 1# first, for Group 2, Treatment 2# will be received first. Then, it takes 2-week washout period with regular dialysis 3 times per week and make Group 1 and Group 2 crossover. Outcomes will include blood pressure changes, nursing intervention frequencies, IDH frequencies, the degree of cold intolerance, the degree of fatigue after dialysis and recovery time from fatigue after dialysis, the percentage of target ultrafiltration achieved and blood biochemistry. Data will be collected at the beginning of the study (baseline), end of Treatment 1 # , and end of Treatment 2#. Subjective questionnaires will be collected before and after each treatment period. The difference of evaluation scores between baseline and post-treatment will be analyzed using generalized linear mixed model. A value of P \< 0.05 will be regarded as statistically significant for the above statistical analyses.

Interventions

DEVICEHEALTHY BOX Powered heating pad (electronic moxibustion)

Using heating pad (electronic moxibustion) with insulating materials on low temperatures (56±8℃) in treating patients with intra-dialytic hypotension

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

30 eligible participants diagnosed with IDH will be enrolled and divided randomly and equally into Group 1 and Group 2 . Treatment 1# will be regular dialysis 3 times per week for 4 weeks. Treatment 2# will be regular dialysis 3 times per week plus HEALTHY BOX Powered heating pad on acupoint CV4 at the abdomen for 1 hour during dialysis, also for 4 weeks. For Group 1, each subject will receive Treatment 1# first, for Group 2, Treatment 2# will be received first. Then, a 2-week washout period with regular dialysis 3 times per week will be carried out. Group 1 will then receive Treatment 2# and Group 2 will then receive Treatment 1#. Subjective questionnaires will be done before and after each Treatment period.

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 20 to 80-years-old 2. Willing to sign inform consent 3. Weekly hemodialysis 3 times per week, each time at least 180 minutes 4. During the past 2 months of hemodialysis, there is symptomatic intra-dialytic hypotension for over 15% of the time or under regular use of Midodrine.

Exclusion criteria

1. Pregnancy or breast-feeding 2. Not able to fill out questionnaires 3. Severe comorbidities, including cirrhosis, heart failure, autoimmune diseases and cancer 4. Diabetic peripheral neuropathy or patients insensitive to heat or unable to effectively express themselves in heated situations 5. Undergoing other types of alternative treatment, including Chinese medicine and regional remedies.

Design outcomes

Primary

MeasureTime frameDescription
change of frequency of IDH episodesbaseline, Treatment 1, Treatment 2times of IDH episode according to NADIR, KDOQI criteria
change of number of nursing interventions during HDbaseline, Treatment 1, Treatment 2Trendelenburg position, man¬ual reduction of ultrafiltration rate, infusion of isotonic saline or hypertonic fluid, lowering of dialysate temperature

Secondary

MeasureTime frameDescription
change of the degree of cold intoleranceweek 0,4,6,10from 0 to 100; 0 is not cold, 100 is very cold
change of the degree of fatigue after dialysisbefore and after Treatment1 & 2scores from 0-10;0 is not tired, 10 is very tired
blood pressure changesbaseline, Treatment 1, Treatment 2systolic, diastolic blood pressure and mean arterial pressure: mmHg
change of recovery time from fatigue after dialysisbefore and after Treatment1 & 2within minutes (0), when arriving home (0), at bedtime (2), the next morning (5), and by next HD (10)

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026